K Kutz
Overview
Explore the profile of K Kutz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofheinz R, Porta C, Hartung G, Santoro A, Hanauske A, Kutz K, et al.
Invest New Drugs
. 2005 Jul;
23(4):363-8.
PMID: 16012796
BBR 3438, a member of the 9-aza-anthrapyrazole family designed to decrease anthracycline dependent cardiotoxicity and to improve efficacy provided high in vivo activity in gastric carcinoma xenograft models. The present...
2.
Dieterle W, Mann J, Kutz K
Int J Clin Pharmacol Ther
. 2005 Jun;
43(4):178-86.
PMID: 15966464
Background: SPP301 is a competitive antagonist of ET-1 with a high selectivity for the ET(A) receptor. The multiple-dose pharmacokinetics, pharmacodynamics, safety and tolerability of SPP301 were investigated in healthy male...
3.
Gaedicke G, Erttmann R, Henze G, Hartmann W, Drechsler S, Grass P, et al.
Pediatr Hematol Oncol
. 1996 Sep;
13(5):405-16.
PMID: 10897812
A pharmacokinetic study in children was performed to assess whether the pharmacokinetic profile of tropisetron in pediatric patients in similar to that in adults. In three pediatric centers, three dosages...
4.
Appel S, Rufenacht T, Kalafsky G, Tetzloff W, Kallay Z, Hitzenberger G, et al.
Am J Cardiol
. 1995 Jul;
76(2):29A-32A.
PMID: 7604792
Human drug interaction studies in vivo are conducted when in vitro and/or animal interactions suggest clinical relevance. Studies in vitro have indicated that the new, entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A...
5.
Fluckiger S, Schmidt C, Meyer A, Kallay Z, Johnston A, Kutz K
J Clin Pharmacol
. 1995 Jul;
35(7):681-7.
PMID: 7560248
Cyclosporine pharmacokinetics were reported to be influenced in patients with Crohn's disease. To explore the relationship between Crohn's disease and cyclosporine pharmacokinetics, this investigation was performed in 20 patients with...
6.
Mueller E, Kallay Z, Kovarik J, Arns W, Renner E, Kutz K
Transplant Proc
. 1995 Feb;
27(1):834-6.
PMID: 7879198
No abstract available.
7.
Holt D, Mueller E, Kovarik J, van Bree J, Richard F, Kutz K
Transplant Proc
. 1995 Feb;
27(1):1434-7.
PMID: 7878935
No abstract available.
8.
Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine
Mueller E, Kovarik J, Kutz K
Transplant Proc
. 1994 Oct;
26(5):2957-8.
PMID: 7940933
No abstract available.
9.
Holt D, Mueller E, Kovarik J, van Bree J, Kutz K
Transplant Proc
. 1994 Oct;
26(5):2935-9.
PMID: 7940927
No abstract available.
10.
Kovarik J, Vernillet L, Mueller E, Freiburghaus R, NIEDERBERGER W, Kutz K
Ther Drug Monit
. 1994 Oct;
16(5):519-25.
PMID: 7846753
Several lines of evidence suggest that cyclosporine may undergo prehepatic metabolism, the possible contribution of which to the overall biotransformation of the drug is, however, unclear. A recently developed oral...